[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354582-105":59,"doc-detail-354582-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","subtype-specific-mechanisms-of-lipid-metabolism-in-gynecological-malignancies-and-novel-targeted-intervention-strategies-review","Subtype‑specific mechanisms of lipid metabolism in gynecological malignancies and novel targeted intervention strategies - Review","","Dysregulated lipid metabolism acts as a core metabolic hallmark across ovarian, endometrial and cervical malignancies, shaping initiation, progression, therapeutic resistance and prognosis. Distinct pathological and molecular subtypes show heterogeneous, subtype‑specific lipid metabolic reprogramming, including enhanced fatty acid oxidation, SREBP1‑driven lipogenesis and human papillomavirus‑mediated cholesterol dysregulation. These alterations promote malignant phenotypes, with mitochondrial lipid metabolism central to therapy resistance. The review systematizes mechanisms, summarizes targeted intervention advances and discusses future challenges for precision gynecologic oncology.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/subtype-specific-mechanisms-of-lipid-metabolism-in-gynecological-malignancies-and-novel-targeted-intervention-strategies-review/354582/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/subtype-specific-mechanisms-of-lipid-metabolism-in-gynecological-malignancies-and-novel-targeted-intervention-strategies-review/354582.png","ImageObject",300,407,{"name":92,"@type":93},"PakDamar76","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does dysregulated lipid metabolism influence gynecological cancer outcomes?","Question",{"text":112,"@type":113},"It drives tumor initiation and progression while contributing to malignant phenotypes, therapeutic resistance and prognosis in ovarian, endometrial and cervical cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What are examples of subtype-specific lipid metabolic patterns across these cancers?",{"text":117,"@type":113},"High-grade serous ovarian cancer can show enhanced fatty acid oxidation, obesity-associated endometrial cancer may exhibit SREBP1-driven lipogenesis, and HPV-mediated cervical cancer can present cholesterol dysregulation.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the review cover regarding targeted intervention strategies?",{"text":121,"@type":113},"It summarizes the latest progress in lipid metabolism-targeted intervention strategies and their clinical translation, and discusses remaining challenges and future directions.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354582,1790188699,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893057,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","ONCOLOGY LETTERS 32: 445, 2026  \nSubtype‑specific mechanisms of lipid metabolism in gynecological malignancies and novel targeted intervention strategies (Review)  \nYIDAN RAN  \nMedical College, Henan Polytechnic University, Jiaozuo, Henan 454150, P.R. China  \nReceived March 5, 2026; Accepted July 15, 2026  \nDOI: 10. 3892/ol.2026.15800  \nAbstract. Dysregulated lipid metabolism, a core metabolic hallmark of gynecological malignancies, plays a pivotal role in the initiation, progression, therapeutic resistance and prognosis of ovarian cancer, endometrial cancer and cervical cancer. Distinct pathological and molecular subtypes of ovarian, endometrial and cervical cancer exhibit highly heterogeneous and subtype‑specific lipid metabolic repro‑ gramming patterns, with core phenotypes ranging from enhanced fatty acid oxidation in high‑grade serous ovarian cancer to sterol regulatory element‑binding protein 1‑driven lipogenesis in obesity‑associated endometrial cancer and human papillomavirus‑mediated cholesterol dysregulation in cervical cancer. These subtype‑specific metabolic altera‑ tions drive tumor progression by mediating key malignant phenotypes, with mitochondrial lipid metabolism playing a central regulatory role in therapeutic resistance. The present review systematically summarizes the subtype‑specific features of lipid metabolic dysregulation in gynecological malignancies, elaborates on the underlying molecular regula‑ tory mechanisms, and summarizes the latest progress in lipid metabolism‑targeted intervention strategies and their clinical translation. Finally, the current challenges and future direc‑ tions in this field are discussed, aiming to provide new insightsand theoretical support for the precision treatment of gyneco‑ logical malignancies.  \nContents  \n1. Introduction  \n2. Subtype‑specific features of dysregulated lipid metabolism in gynecological malignancies  \nCorrespondence to: Professor Yidan Ran, Medical College, Henan Polytechnic University, 142 Jiefang Middle Road, Jiefang, Jiaozuo, Henan 454150, P.R. China  \nE‑mail: [15137066765@163.com](15137066765@163.com)  \nKey words: gynecological malignancy, lipid metabolism, subtype‑specificity, targeted therapy  \n3. Key links and regulatory networks of abnormal lipid metabolism  \n4. Associations between dysregulated lipid metabolism and malignant tumor phenotypes  \n5. Lipid metabolism‑targeted intervention strategies and clinical translation  \n6. Challenges and future perspectives  \n1. Introduction  \nGynecological malignancies represent a major threat to health, with ovarian, endometrial cancer and cervical cancer ranking among the most prevalent and lethal neoplasms of the female reproductive tract (1‑3) . Statistics indicate that >1.3 million new cases of gynecological malignancies and nearly 500,000 associated deaths are reported globally each year. Ovarian cancer, in particular, is characterized by insidious onset and challenges in early diagnosis, with >70% of patients presenting at an advanced stage (International Federation of Gynecology and Obstetrics stage III/IV) atthe time of diagnosis (4,5). While primary debulking surgery combined with platinum‑based chemotherapy can achieve initial remission, the postopera‑ tive recurrence rate of ovarian cancer is >70%, with a 5‑year survival rate of only ~30% . Platinum resistance stands as the primary bottleneck contributing to treatment failure (6,7) . Endometrial cancer has witnessed a steady rise in incidence, with obesity‑associated type I endometrial cancer (Bokhman classification) accounting for >80% of cases and conferring a poor prognosis (8) . For advanced or recurrent endometrial cancer, therapeutic options remain limited, as immune check‑ point inhibitors only benefit a subset of patients with mismatch repair‑deficient subtypes (9) . Although early intervention for cervical cancer is feasible through human papillomavirus (HPV) vaccination and screening, high‑risk subtypes associ‑ ated with persistent HPV","cbCaiu7ReljPY8EN","https://ap.wps.com/l/cbCaiu7ReljPY8EN","pdf",2402667,18,"English","# Introduction\n## Subtype-specific features of dysregulated lipid metabolism in gynecological malignancies\n## Key links and regulatory networks of abnormal lipid metabolism\n## Associations between dysregulated lipid metabolism and malignant tumor phenotypes\n## Lipid metabolism-targeted intervention strategies and clinical translation\n## Challenges and future perspectives","[{\"question\":\"How does dysregulated lipid metabolism influence gynecological cancer outcomes?\",\"answer\":\"It drives tumor initiation and progression while contributing to malignant phenotypes, therapeutic resistance and prognosis in ovarian, endometrial and cervical cancers.\"},{\"question\":\"What are examples of subtype-specific lipid metabolic patterns across these cancers?\",\"answer\":\"High-grade serous ovarian cancer can show enhanced fatty acid oxidation, obesity-associated endometrial cancer may exhibit SREBP1-driven lipogenesis, and HPV-mediated cervical cancer can present cholesterol dysregulation.\"},{\"question\":\"What does the review cover regarding targeted intervention strategies?\",\"answer\":\"It summarizes the latest progress in lipid metabolism-targeted intervention strategies and their clinical translation, and discusses remaining challenges and future directions.\"}]","Subtype‑specific mechanisms of lipid metabolism in gynecological malignancies and novel targeted intervention strategies - Review | PDF",1790112280,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89bff9d4ade698818636e52c7f901b8c.webp",983,1357,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/63d352049cce9c78bd057424602d0412.webp",982,1356,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/328b96c88855b1606691c7cc05142873.webp",981,1354,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b1e0550970d18e0749b6b1ef2c68ffc.webp",980,1353]